News & Updates

Use of stimulants remains high among patients with psychocutaneous disease, most of whom have one or more psychiatric comorbidity, results of a recent study have shown.

The human monoclonal IgG4 antibody dupilumab effectively treats prurigo nodularis (PN), including itching and skin lesions, weeks after treatment in the phase III randomized, double-blind, LIBERTY-PN PRIME2 trial. Hopefully, this brings relief to patients suffering from uncontrolled PN.

Skin reactions to the first COVID-19 vaccine in some individuals shouldn’t be a reason to leave out the second dose, or a scheduled booster if tolerable, according to an analysis presented at AAD 2022.

Using a topical roflumilast cream to treat patients with chronic plaque psoriasis yields a significant improvement in disease severity, achieving a clear or almost clear IGA* status, based on a pooled analysis of the DERMIS-1** and DERMIS-2*** studies presented at AAD 2022.

The presence of lymphovascular invasion (LVI) in patients with cutaneous squamous cell carcinoma is associated with higher rates of metastasis and death at 5 years, reveals a recent study, noting that future staging systems must incorporate LVI.